Prednicarbate

Table of contents

  • Brand Names
  • Chemistry
  • Pharmacologic Category
  • Mechanism of Action
  • Therapeutic Use
  • Contraindications
  • Warnings and Precautions
  • Adverse Reactions
  • Dosage
  • Special Considerations

Brand Names

Europe

Austria: Prednitop; Bulgaria: Dermatop; Czech Republic: Dermatop; Germany: Dermatop, Prednicarbat, Prednitop; Greece: Dermatop; Italy: Dermatop; Slovakia: Dermatop; Spain: Batmen, Peitel.

North America

Canada: Dermatop; USA: Dermatop, Prednicarbate.

Latin America

Brazil: Dermatop, Invex; Mexico: Alisyd.

Drug combinations

Chemistry

Prednicarbate: C~27~H~36~O~8~. Mw: 488.57. (1) Pregna-1,4-diene-3,20-dione, 17-[(ethoxycarbonyl)oxy]-11-hydroxy-21-(1-oxopropoxy)-, (11β)-; (2) 11β,17,21-Trihydroxypregna-1,4-diene-3,20-dione 17-(ethyl carbonate) 21-propionate. CAS-73771-04-7 (1983).

Pharmacologic Category

Skin and Mucous Membrane Agents; Anti-inflammatory Agents. Topical Corticosteroid. (ATC-Code: D07AC18).

Mechanism of action

Topical corticosteroids have anti-inflammatory, antipruritic, vasoconstrictive, and antiproliferative actions.

Therapeutic use

Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Pregnancy and lactiation implications

Unlabeled use

Contraindications

Hypersensitivity to prednicarbate or any component of the formulation. Fungal, viral, or tubercular skin lesions, herpes simplex or herpes zoster.

Warnings and precautions

Systemic absorption of topical corticosteroids may cause hypothalamic-pituitary-adrenal axis suppression (reversible) particularly in younger children, which may lead to adrenal crisis. Risk increased when used over large surface areas, for prolonged periods, or with occlusive dressings. Allergic contact dermatitis can occur. Prolonged treatment with corticosteroids associated with development of Kaposi’s sarcoma (case reports). Adverse systemic effects including hyperglycemia, glycosuria, fluid and electrolyte changes, and HPA suppression may occur when used on large surface areas, for prolonged periods, or with occlusive dressing. Should not be used for diaper dermatitis. Chronic use of corticosteroids in children may interfere with growth and development.

Information

Legal

Legal Notice
Privacy Policy
Cookie Policy

Contact

Phone: +34-981-780505
Email: genomicmedicine@wagem.org
Location: Sta Marta de, C. P. Babío, S/N, 15165 Bergondo, A Coruña

Copyright © 2023 WAGEM

Add to cart